Tirzepatide

Tirzepatide is a dual agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, amplifying the effects of both incretin hormones. This dual action enhances insulin secretion, reduces glucagon levels, and improves glucose regulation more effectively than single-pathway agonists. Additionally, Tirzepatide influences metabolic signaling pathways to support energy balance and lipid metabolism, contributing to improved nutrient processing and storage.

Tirzepatide

Tirzepatide Overview

• Type: Dual Agonist
• Targets:
  • GLP-1 (Glucagon-like peptide-1)
  • GIP (Glucose-dependent insulinotropic polypeptide)

Mechanism of Action

• Insulin Secretion: Enhances insulin release in response to meals.
• Glucagon Levels: Reduces glucagon secretion, which helps lower blood glucose levels.
• Glucose Regulation: More effective than single-pathway agonists in managing blood sugar.

Additional Effects

• Metabolic Signaling: Influences pathways that regulate energy balance.
• Lipid Metabolism: Supports better processing and storage of nutrients.

Benefits

• Improved glucose regulation.
• Enhanced weight management and metabolic health.